Please wait while the formulary information is being retrieved.
REVLIMID (LENALIDOMIDE)
- Follicular lymphoma
- Mantle cell lymphoma
- Marginal zone lymphoma
- Multiple myeloma
- Multiple myeloma maintenance therapy following auto-HSCT
- Myelodysplastic syndrome with 5q deletion
10 mg capsule
- 1 capsule (10 mg) by oral route once daily
15 mg capsule
- 1 capsule (15 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
2.5 mg capsule
- 1 capsule (2.5 mg) by oral route once daily
20 mg capsule
- 1 capsule (20 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
25 mg capsule
- 1 capsule (25 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
5 mg capsule
- 1 capsule (5 mg) by oral route once daily
Follicular lymphoma
- 2 capsules (5 mg) by oral route once daily
- 1 capsule (5 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 1 capsule (10 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 2 capsules (10 mg) by oral route once daily on days 1 through 21Of a 28 day treatment cycle
- 1 capsule (20 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 2 capsules (20 mg) by oral route once daily on days 1 through 21Of a 28 day treatment cycle
- 1 capsule (2.5 mg) by oral route once daily
Mantle cell lymphoma
- 1 capsule (5 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 1 capsule (10 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 2 capsules (10 mg) by oral route once daily on days 1 through 21Of a 28 day treatment cycle
- 1 capsule (15 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 1 capsule (20 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 2 capsules (20 mg) by oral route once daily on days 1 through 21Of a 28 day treatment cycle
- 1 capsule (25 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
Marginal zone lymphoma
- 2 capsules (5 mg) by oral route once daily
- 1 capsule (5 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 1 capsule (10 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 2 capsules (10 mg) by oral route once daily on days 1 through 21Of a 28 day treatment cycle
- 1 capsule (20 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 2 capsules (20 mg) by oral route once daily on days 1 through 21Of a 28 day treatment cycle
- 1 capsule (2.5 mg) by oral route once daily
Multiple myeloma
- 1 capsule (5 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 1 capsule (10 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 2 capsules (10 mg) by oral route once daily on days 1 through 21Of a 28 day treatment cycle
- 1 capsule (15 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 1 capsule (20 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 2 capsules (20 mg) by oral route once daily on days 1 through 21Of a 28 day treatment cycle
- 1 capsule (25 mg) by oral route once daily on days 1 through 21 of a 28 day treatment cycle
- 1 capsule (2.5 mg) by oral route once daily on days 1-21 of a 28Day treatment cycle
Multiple myeloma maintenance therapy following auto-HSCT
- 1 capsule (5 mg) by oral route once daily
- 2 capsules (10 mg) by oral route once daily
- 1 capsule (10 mg) by oral route once daily
- 1 capsule (15 mg) by oral route once daily
Myelodysplastic syndrome with 5q deletion
- 2 capsules (5 mg) by oral route once daily
- 1 capsule (5 mg) by oral route once daily
- 2 capsules (10 mg) by oral route once daily
- 1 capsule (10 mg) by oral route once daily
- 1 capsule (2.5 mg) by oral route once daily
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- BCG vaccine, live (PF)
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- M-m-r Ii (pf)
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- natalizumab
- Proquad (pf)
- Rotateq Vaccine
- rotavirus vaccine live, penta
- typhoid vaccine
- Tysabri
- varicella virus vacc live (PF)
- Varivax (pf)
- Vivotif Berna Vaccine
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- clozapine
- Clozaril
- deferiprone
- Fazaclo
- Ferriprox
- Versacloz
Severe
Moderate
- None
- Lactating mother
- Pregnancy
Contraindicated
- Acute myocardial infarction
- Acute thromboembolic stroke
- Chronic kidney disease stage 3A (moderate) GFR 45-59
- Chronic kidney disease stage 3B (moderate) GFR 30-44
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Chronic kidney disease stage 5 (failure) GFr<15 ml/min
- Deep venous thrombosis
- Disease of liver
- Pulmonary thromboembolism
- Severe neutropenic disorder
- Severe thrombocytopenia
- Thromboembolic disorder
Severe
Moderate
- Hodgkin's lymphoma
- Hyperthyroidism
- Hypothyroidism
- Secondary acute myeloid leukemia
REVLIMID (LENALIDOMIDE)
- Follicular lymphoma
- Mantle cell lymphoma
- Marginal zone lymphoma
- Multiple myeloma
- Multiple myeloma maintenance therapy following auto-HSCT
- Myelodysplastic syndrome with 5q deletion
- Anemia
- Dyspnea
- Leukopenia
- Neutropenic disorder
- Thrombocytopenic disorder
- Acute abdominal pain
- Arthralgias
- Back pain
- Constipation
- Cough
- Cramps
- Diarrhea
- Dizziness
- Dry skin
- Epistaxis
- Fatigue
- Fever
- General weakness
- Headache disorder
- Hypesthesia
- Nausea
- Peripheral edema
- Pharyngitis
- Pruritus of skin
- Skin rash
- Tremor
- Upper respiratory infection
- Weight loss
More Frequent
Severe
Less Severe
- Atrial fibrillation
- Bronchitis
- Chest pain
- Deep venous thrombosis
- Dehydration
- Edema
- Hypocalcemia
- Hypokalemia
- Hypophosphatemia
- Infection
- Lymphopenia
- Peripheral neuropathy
- Pneumonia
- Squamous cell carcinoma
- Thromboembolic disorder
- Anorexia
- Basal cell carcinoma of skin
- Blurred vision
- Bruising
- Cellulitis
- Chills
- Depression
- Dysgeusia
- Ecchymosis
- Erythema
- Hyperglycemia
- Hyperhidrosis
- Insomnia
- Limb pain
- Loose stools
- Muscle weakness
- Myalgias
- Non-cardiac chest pain
- Paresthesia
- Rhinitis
- Sinusitis
- Urinary tract infection
- Vomiting
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal desquamation
- Abnormal hepatic function tests
- Acute cerebral infarction
- Acute hepatic failure
- Acute myeloid leukemia
- Acute myocardial infarction
- Altered mental status
- Anaphylaxis
- Angioedema
- Arterial aneurysm
- Atrial flutter
- Autoimmune hemolytic anemia
- B-cell acute lymphoblastic leukemia
- Bacteremia
- Bacterial sepsis
- Bullous dermatitis
- Cerebral edema
- Cerebral ischemia
- Cerebrovascular accident
- Chemotherapy-induced hyperuricemia
- Cholestatic hepatitis
- Clostridium difficile infection
- Delirium
- Diabetes mellitus
- DRESS syndrome
- Drug-induced psychosis
- Encephalitis
- Eosinophilia
- Exfoliative dermatitis
- Gastritis
- Gastrointestinal hemorrhage
- Heart failure
- Hematuria
- Hemorrhage
- Hepatitis
- Herpes zoster
- Hodgkin's lymphoma
- Hypersensitivity pneumonitis
- Hypertension
- Hypomagnesemia
- Hypotension
- Hypothyroidism
- Hypoxia
- Increased alanine transaminase
- Kidney disease with reduction in GFR
- Lymphadenopathy
- Lymphedema
- Myelodysplastic syndrome
- Organ transplant rejection
- Orthostatic hypotension
- Pancreatitis
- Pancytopenia
- Phlebitis
- Progressive multifocal leukoencephalopathy
- Pulmonary edema
- Pulmonary thromboembolism
- Reactivation of hepatitis B
- Renal failure
- Renal tubular necrosis
- Rhabdomyolysis
- Stevens-johnson syndrome
- Sudden visual loss
- Supraventricular tachycardia
- Sweet's syndrome
- Thrombophlebitis
- Thrombotic disorder
- Toxic epidermal necrolysis
- Urinary retention
- Vision loss
Less Severe
- Angina
- Ataxia
- Drowsy
- Dysuria
- Erectile dysfunction
- Flushing
- Gait abnormality
- Hallucinations
- Hirsutism
- Hoarseness
- Hyperthyroidism
- Hyperuricemia
- Libido changes
- Malaise
- Mood changes
- Night sweats
- Ocular hypertension
- Pallor
- Palpitations
- Petechiae
- Raynaud's phenomenon
- Skin pigmentation enhancement
- Sore tongue
- Varicose veins
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Lenalidomide
Safety and efficacy not established in pediatrics age < 18 years.
- 1 Day – 18 Years
- Safety and efficacy not established in pediatrics age < 18 years.
Lenalidomide
- Severity Level:
1
- Additional Notes: Teratogenic thalidomide analogue; use contraception during and 4 wks after tx
Contraindicated
Lenalidomide
Potential serious adverse effects on infant based on drug pharmacology
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Potential serious adverse effects on infant based on drug pharmacology |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Lenalidomide
Gastrointestinal-Increased incidence of diarrhea and fatigue reported. Cardiovascular-Elderly more likely to experience DVT, pulmonary embolism, atrial fibrillation and syncope. Renal-Higher risk of adverse effects with renal impairment. Monitor renal function. Reduce dose for CrCL<61 mL/min.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | Y | N | Y | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- Lenalidomide is very similar to thalidomide, a drug which has caused severe (possibly fatal) birth defects when used during pregnancy. If lenalidomide is taken during pregnancy, it may also cause severe (possibly fatal) birth defects. Women who are pregnant or who may become pregnant must not use lenalidomide.<br /><br />Women must have two negative pregnancy tests before starting lenalidomide (the first test 10 to 14 days before the first dose and the second test within 24 hours before the first dose). Women must also continue to have pregnancy tests regularly during treatment (every 2 to 4 weeks). Female patients must use 2 effective forms of birth control (or completely avoid sexual intercourse) for 4 weeks before starting lenalidomide, during use, and for 4 weeks after stopping this drug.<br /><br />Talk to your doctor about reliable birth control choices. If your period is late or if you have irregular bleeding, or if you have sexual intercourse at any time without using 2 effective forms of birth control, stop taking this medication and contact your doctor right away. Because lenalidomide also passes into semen, men who use this drug and have sex with women must use a latex condom during all sexual contact, even if they have had a vasectomy.<br /><br />Continue using condoms and other birth control as directed until 4 weeks after lenalidomide treatment has been stopped. You should have a blood test for hepatitis B virus before starting treatment. Some people with this virus may have a serious flare-up when using lenalidomide.<br /><br /> To receive this medication, all doctors, pharmacists, and patients must understand, agree to, and carefully follow the requirements of the Revlimid REMS Program created by the U.S. Food and Drug Administration.<br /><br />These requirements apply in the United States. If you live in Canada or any other country, consult your doctor and pharmacist for your country's regulations. This medication may cause a low number of white blood cells and platelets.<br /><br />Your doctor will monitor you closely while you take this medication and may adjust the dose of the medication or stop the medication based on your lab test results. Get medical help right away if you develop any of the following symptoms: signs of infection (such as sore throat that doesn't go away, fever, swollen lymph nodes, chills, cough), easy bleeding/bruising. Lenalidomide may rarely cause blood clots (such as pulmonary embolism, stroke, heart attack, deep vein thrombosis).<br /><br />You may be at increased risk for blood clots if you smoke, or have a history of blood clots, high blood pressure, or high cholesterol, or if you are immobile (such as on very long plane flights or being bedridden). If you use estrogen-containing products, these may also increase your risk. To lower your risk, your doctor may prescribe an additional medication.<br /><br />Before using lenalidomide, if you have any of these conditions report them to your doctor or pharmacist. Get medical help right away if you have any signs of a blood clot, including: shortness of breath, chest/jaw/left arm pain, unusual sweating, confusion, pain/swelling/redness in the groin/calf, sudden/severe headaches, slurred speech, weakness on one side of the body, sudden vision changes.
| Follicular lymphoma | |
| C82 | Follicular lymphoma |
| C82.0 | Follicular lymphoma grade I |
| C82.00 | Follicular lymphoma grade i, unspecified site |
| C82.01 | Follicular lymphoma grade i, lymph nodes of head, face, and neck |
| C82.02 | Follicular lymphoma grade i, intrathoracic lymph nodes |
| C82.03 | Follicular lymphoma grade i, intra-abdominal lymph nodes |
| C82.04 | Follicular lymphoma grade i, lymph nodes of axilla and upper limb |
| C82.05 | Follicular lymphoma grade i, lymph nodes of inguinal region and lower limb |
| C82.06 | Follicular lymphoma grade i, intrapelvic lymph nodes |
| C82.07 | Follicular lymphoma grade i, spleen |
| C82.08 | Follicular lymphoma grade i, lymph nodes of multiple sites |
| C82.09 | Follicular lymphoma grade i, extranodal and solid organ sites |
| C82.1 | Follicular lymphoma grade II |
| C82.10 | Follicular lymphoma grade Ii, unspecified site |
| C82.11 | Follicular lymphoma grade Ii, lymph nodes of head, face, and neck |
| C82.12 | Follicular lymphoma grade Ii, intrathoracic lymph nodes |
| C82.13 | Follicular lymphoma grade Ii, intra-abdominal lymph nodes |
| C82.14 | Follicular lymphoma grade Ii, lymph nodes of axilla and upper limb |
| C82.15 | Follicular lymphoma grade Ii, lymph nodes of inguinal region and lower limb |
| C82.16 | Follicular lymphoma grade Ii, intrapelvic lymph nodes |
| C82.17 | Follicular lymphoma grade Ii, spleen |
| C82.18 | Follicular lymphoma grade Ii, lymph nodes of multiple sites |
| C82.19 | Follicular lymphoma grade Ii, extranodal and solid organ sites |
| C82.2 | Follicular lymphoma grade IIi, unspecified |
| C82.20 | Follicular lymphoma grade IIi, unspecified, unspecified site |
| C82.21 | Follicular lymphoma grade IIi, unspecified, lymph nodes of head, face, and neck |
| C82.22 | Follicular lymphoma grade IIi, unspecified, intrathoracic lymph nodes |
| C82.23 | Follicular lymphoma grade IIi, unspecified, intra-abdominal lymph nodes |
| C82.24 | Follicular lymphoma grade IIi, unspecified, lymph nodes of axilla and upper limb |
| C82.25 | Follicular lymphoma grade IIi, unspecified, lymph nodes of inguinal region and lower limb |
| C82.26 | Follicular lymphoma grade IIi, unspecified, intrapelvic lymph nodes |
| C82.27 | Follicular lymphoma grade IIi, unspecified, spleen |
| C82.28 | Follicular lymphoma grade IIi, unspecified, lymph nodes of multiple sites |
| C82.29 | Follicular lymphoma grade IIi, unspecified, extranodal and solid organ sites |
| C82.3 | Follicular lymphoma grade IIia |
| C82.30 | Follicular lymphoma grade IIia, unspecified site |
| C82.31 | Follicular lymphoma grade IIia, lymph nodes of head, face, and neck |
| C82.32 | Follicular lymphoma grade IIia, intrathoracic lymph nodes |
| C82.33 | Follicular lymphoma grade IIia, intra-abdominal lymph nodes |
| C82.34 | Follicular lymphoma grade IIia, lymph nodes of axilla and upper limb |
| C82.35 | Follicular lymphoma grade IIia, lymph nodes of inguinal region and lower limb |
| C82.36 | Follicular lymphoma grade IIia, intrapelvic lymph nodes |
| C82.37 | Follicular lymphoma grade IIia, spleen |
| C82.38 | Follicular lymphoma grade IIia, lymph nodes of multiple sites |
| C82.39 | Follicular lymphoma grade IIia, extranodal and solid organ sites |
| C82.4 | Follicular lymphoma grade IIib |
| C82.40 | Follicular lymphoma grade IIib, unspecified site |
| C82.41 | Follicular lymphoma grade IIib, lymph nodes of head, face, and neck |
| C82.42 | Follicular lymphoma grade IIib, intrathoracic lymph nodes |
| C82.43 | Follicular lymphoma grade IIib, intra-abdominal lymph nodes |
| C82.44 | Follicular lymphoma grade IIib, lymph nodes of axilla and upper limb |
| C82.45 | Follicular lymphoma grade IIib, lymph nodes of inguinal region and lower limb |
| C82.46 | Follicular lymphoma grade IIib, intrapelvic lymph nodes |
| C82.47 | Follicular lymphoma grade IIib, spleen |
| C82.48 | Follicular lymphoma grade IIib, lymph nodes of multiple sites |
| C82.49 | Follicular lymphoma grade IIib, extranodal and solid organ sites |
| C82.5 | Diffuse follicle center lymphoma |
| C82.50 | Diffuse follicle center lymphoma, unspecified site |
| C82.51 | Diffuse follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.52 | Diffuse follicle center lymphoma, intrathoracic lymph nodes |
| C82.53 | Diffuse follicle center lymphoma, intra-abdominal lymph nodes |
| C82.54 | Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.55 | Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.56 | Diffuse follicle center lymphoma, intrapelvic lymph nodes |
| C82.57 | Diffuse follicle center lymphoma, spleen |
| C82.58 | Diffuse follicle center lymphoma, lymph nodes of multiple sites |
| C82.59 | Diffuse follicle center lymphoma, extranodal and solid organ sites |
| C82.6 | Cutaneous follicle center lymphoma |
| C82.60 | Cutaneous follicle center lymphoma, unspecified site |
| C82.61 | Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.62 | Cutaneous follicle center lymphoma, intrathoracic lymph nodes |
| C82.63 | Cutaneous follicle center lymphoma, intra-abdominal lymph nodes |
| C82.64 | Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.65 | Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.66 | Cutaneous follicle center lymphoma, intrapelvic lymph nodes |
| C82.67 | Cutaneous follicle center lymphoma, spleen |
| C82.68 | Cutaneous follicle center lymphoma, lymph nodes of multiple sites |
| C82.69 | Cutaneous follicle center lymphoma, extranodal and solid organ sites |
| C82.8 | Other types of follicular lymphoma |
| C82.80 | Other types of follicular lymphoma, unspecified site |
| C82.81 | Other types of follicular lymphoma, lymph nodes of head, face, and neck |
| C82.82 | Other types of follicular lymphoma, intrathoracic lymph nodes |
| C82.83 | Other types of follicular lymphoma, intra-abdominal lymph nodes |
| C82.84 | Other types of follicular lymphoma, lymph nodes of axilla and upper limb |
| C82.85 | Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C82.86 | Other types of follicular lymphoma, intrapelvic lymph nodes |
| C82.87 | Other types of follicular lymphoma, spleen |
| C82.88 | Other types of follicular lymphoma, lymph nodes of multiple sites |
| C82.89 | Other types of follicular lymphoma, extranodal and solid organ sites |
| C82.9 | Follicular lymphoma, unspecified |
| C82.90 | Follicular lymphoma, unspecified, unspecified site |
| C82.91 | Follicular lymphoma, unspecified, lymph nodes of head, face, and neck |
| C82.92 | Follicular lymphoma, unspecified, intrathoracic lymph nodes |
| C82.93 | Follicular lymphoma, unspecified, intra-abdominal lymph nodes |
| C82.94 | Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C82.95 | Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C82.96 | Follicular lymphoma, unspecified, intrapelvic lymph nodes |
| C82.97 | Follicular lymphoma, unspecified, spleen |
| C82.98 | Follicular lymphoma, unspecified, lymph nodes of multiple sites |
| C82.99 | Follicular lymphoma, unspecified, extranodal and solid organ sites |
| Mantle cell lymphoma | |
| C83.1 | Mantle cell lymphoma |
| C83.10 | Mantle cell lymphoma, unspecified site |
| C83.11 | Mantle cell lymphoma, lymph nodes of head, face, and neck |
| C83.12 | Mantle cell lymphoma, intrathoracic lymph nodes |
| C83.13 | Mantle cell lymphoma, intra-abdominal lymph nodes |
| C83.14 | Mantle cell lymphoma, lymph nodes of axilla and upper limb |
| C83.15 | Mantle cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.16 | Mantle cell lymphoma, intrapelvic lymph nodes |
| C83.17 | Mantle cell lymphoma, spleen |
| C83.18 | Mantle cell lymphoma, lymph nodes of multiple sites |
| C83.19 | Mantle cell lymphoma, extranodal and solid organ sites |
| Marginal zone lymphoma | |
| C83.0 | Small cell b-cell lymphoma |
| C83.00 | Small cell b-cell lymphoma, unspecified site |
| C83.01 | Small cell b-cell lymphoma, lymph nodes of head, face, and neck |
| C83.02 | Small cell b-cell lymphoma, intrathoracic lymph nodes |
| C83.03 | Small cell b-cell lymphoma, intra-abdominal lymph nodes |
| C83.04 | Small cell b-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.05 | Small cell b-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.06 | Small cell b-cell lymphoma, intrapelvic lymph nodes |
| C83.07 | Small cell b-cell lymphoma, spleen |
| C83.08 | Small cell b-cell lymphoma, lymph nodes of multiple sites |
| C83.09 | Small cell b-cell lymphoma, extranodal and solid organ sites |
| Multiple myeloma | |
| C90.0 | Multiple myeloma |
| C90.00 | Multiple myeloma not having achieved remission |
| C90.02 | Multiple myeloma in relapse |
| Multiple myeloma maintenance therapy following auto-HSCT | |
| C90.0 | Multiple myeloma |
| C90.00 | Multiple myeloma not having achieved remission |
| Myelodysplastic syndrome with 5q deletion | |
| D46.C | Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality |
| 0-9 | A-Z |
|---|---|
| C82 | Follicular lymphoma |
| C82.0 | Follicular lymphoma grade I |
| C82.00 | Follicular lymphoma grade i, unspecified site |
| C82.01 | Follicular lymphoma grade i, lymph nodes of head, face, and neck |
| C82.02 | Follicular lymphoma grade i, intrathoracic lymph nodes |
| C82.03 | Follicular lymphoma grade i, intra-abdominal lymph nodes |
| C82.04 | Follicular lymphoma grade i, lymph nodes of axilla and upper limb |
| C82.05 | Follicular lymphoma grade i, lymph nodes of inguinal region and lower limb |
| C82.06 | Follicular lymphoma grade i, intrapelvic lymph nodes |
| C82.07 | Follicular lymphoma grade i, spleen |
| C82.08 | Follicular lymphoma grade i, lymph nodes of multiple sites |
| C82.09 | Follicular lymphoma grade i, extranodal and solid organ sites |
| C82.1 | Follicular lymphoma grade II |
| C82.10 | Follicular lymphoma grade Ii, unspecified site |
| C82.11 | Follicular lymphoma grade Ii, lymph nodes of head, face, and neck |
| C82.12 | Follicular lymphoma grade Ii, intrathoracic lymph nodes |
| C82.13 | Follicular lymphoma grade Ii, intra-abdominal lymph nodes |
| C82.14 | Follicular lymphoma grade Ii, lymph nodes of axilla and upper limb |
| C82.15 | Follicular lymphoma grade Ii, lymph nodes of inguinal region and lower limb |
| C82.16 | Follicular lymphoma grade Ii, intrapelvic lymph nodes |
| C82.17 | Follicular lymphoma grade Ii, spleen |
| C82.18 | Follicular lymphoma grade Ii, lymph nodes of multiple sites |
| C82.19 | Follicular lymphoma grade Ii, extranodal and solid organ sites |
| C82.2 | Follicular lymphoma grade IIi, unspecified |
| C82.20 | Follicular lymphoma grade IIi, unspecified, unspecified site |
| C82.21 | Follicular lymphoma grade IIi, unspecified, lymph nodes of head, face, and neck |
| C82.22 | Follicular lymphoma grade IIi, unspecified, intrathoracic lymph nodes |
| C82.23 | Follicular lymphoma grade IIi, unspecified, intra-abdominal lymph nodes |
| C82.24 | Follicular lymphoma grade IIi, unspecified, lymph nodes of axilla and upper limb |
| C82.25 | Follicular lymphoma grade IIi, unspecified, lymph nodes of inguinal region and lower limb |
| C82.26 | Follicular lymphoma grade IIi, unspecified, intrapelvic lymph nodes |
| C82.27 | Follicular lymphoma grade IIi, unspecified, spleen |
| C82.28 | Follicular lymphoma grade IIi, unspecified, lymph nodes of multiple sites |
| C82.29 | Follicular lymphoma grade IIi, unspecified, extranodal and solid organ sites |
| C82.3 | Follicular lymphoma grade IIia |
| C82.30 | Follicular lymphoma grade IIia, unspecified site |
| C82.31 | Follicular lymphoma grade IIia, lymph nodes of head, face, and neck |
| C82.32 | Follicular lymphoma grade IIia, intrathoracic lymph nodes |
| C82.33 | Follicular lymphoma grade IIia, intra-abdominal lymph nodes |
| C82.34 | Follicular lymphoma grade IIia, lymph nodes of axilla and upper limb |
| C82.35 | Follicular lymphoma grade IIia, lymph nodes of inguinal region and lower limb |
| C82.36 | Follicular lymphoma grade IIia, intrapelvic lymph nodes |
| C82.37 | Follicular lymphoma grade IIia, spleen |
| C82.38 | Follicular lymphoma grade IIia, lymph nodes of multiple sites |
| C82.39 | Follicular lymphoma grade IIia, extranodal and solid organ sites |
| C82.4 | Follicular lymphoma grade IIib |
| C82.40 | Follicular lymphoma grade IIib, unspecified site |
| C82.41 | Follicular lymphoma grade IIib, lymph nodes of head, face, and neck |
| C82.42 | Follicular lymphoma grade IIib, intrathoracic lymph nodes |
| C82.43 | Follicular lymphoma grade IIib, intra-abdominal lymph nodes |
| C82.44 | Follicular lymphoma grade IIib, lymph nodes of axilla and upper limb |
| C82.45 | Follicular lymphoma grade IIib, lymph nodes of inguinal region and lower limb |
| C82.46 | Follicular lymphoma grade IIib, intrapelvic lymph nodes |
| C82.47 | Follicular lymphoma grade IIib, spleen |
| C82.48 | Follicular lymphoma grade IIib, lymph nodes of multiple sites |
| C82.49 | Follicular lymphoma grade IIib, extranodal and solid organ sites |
| C82.5 | Diffuse follicle center lymphoma |
| C82.50 | Diffuse follicle center lymphoma, unspecified site |
| C82.51 | Diffuse follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.52 | Diffuse follicle center lymphoma, intrathoracic lymph nodes |
| C82.53 | Diffuse follicle center lymphoma, intra-abdominal lymph nodes |
| C82.54 | Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.55 | Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.56 | Diffuse follicle center lymphoma, intrapelvic lymph nodes |
| C82.57 | Diffuse follicle center lymphoma, spleen |
| C82.58 | Diffuse follicle center lymphoma, lymph nodes of multiple sites |
| C82.59 | Diffuse follicle center lymphoma, extranodal and solid organ sites |
| C82.6 | Cutaneous follicle center lymphoma |
| C82.60 | Cutaneous follicle center lymphoma, unspecified site |
| C82.61 | Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.62 | Cutaneous follicle center lymphoma, intrathoracic lymph nodes |
| C82.63 | Cutaneous follicle center lymphoma, intra-abdominal lymph nodes |
| C82.64 | Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.65 | Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.66 | Cutaneous follicle center lymphoma, intrapelvic lymph nodes |
| C82.67 | Cutaneous follicle center lymphoma, spleen |
| C82.68 | Cutaneous follicle center lymphoma, lymph nodes of multiple sites |
| C82.69 | Cutaneous follicle center lymphoma, extranodal and solid organ sites |
| C82.8 | Other types of follicular lymphoma |
| C82.80 | Other types of follicular lymphoma, unspecified site |
| C82.81 | Other types of follicular lymphoma, lymph nodes of head, face, and neck |
| C82.82 | Other types of follicular lymphoma, intrathoracic lymph nodes |
| C82.83 | Other types of follicular lymphoma, intra-abdominal lymph nodes |
| C82.84 | Other types of follicular lymphoma, lymph nodes of axilla and upper limb |
| C82.85 | Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C82.86 | Other types of follicular lymphoma, intrapelvic lymph nodes |
| C82.87 | Other types of follicular lymphoma, spleen |
| C82.88 | Other types of follicular lymphoma, lymph nodes of multiple sites |
| C82.89 | Other types of follicular lymphoma, extranodal and solid organ sites |
| C82.9 | Follicular lymphoma, unspecified |
| C82.90 | Follicular lymphoma, unspecified, unspecified site |
| C82.91 | Follicular lymphoma, unspecified, lymph nodes of head, face, and neck |
| C82.92 | Follicular lymphoma, unspecified, intrathoracic lymph nodes |
| C82.93 | Follicular lymphoma, unspecified, intra-abdominal lymph nodes |
| C82.94 | Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C82.95 | Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C82.96 | Follicular lymphoma, unspecified, intrapelvic lymph nodes |
| C82.97 | Follicular lymphoma, unspecified, spleen |
| C82.98 | Follicular lymphoma, unspecified, lymph nodes of multiple sites |
| C82.99 | Follicular lymphoma, unspecified, extranodal and solid organ sites |
| C83.0 | Small cell b-cell lymphoma |
| C83.00 | Small cell b-cell lymphoma, unspecified site |
| C83.01 | Small cell b-cell lymphoma, lymph nodes of head, face, and neck |
| C83.02 | Small cell b-cell lymphoma, intrathoracic lymph nodes |
| C83.03 | Small cell b-cell lymphoma, intra-abdominal lymph nodes |
| C83.04 | Small cell b-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.05 | Small cell b-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.06 | Small cell b-cell lymphoma, intrapelvic lymph nodes |
| C83.07 | Small cell b-cell lymphoma, spleen |
| C83.08 | Small cell b-cell lymphoma, lymph nodes of multiple sites |
| C83.09 | Small cell b-cell lymphoma, extranodal and solid organ sites |
| C83.1 | Mantle cell lymphoma |
| C83.10 | Mantle cell lymphoma, unspecified site |
| C83.11 | Mantle cell lymphoma, lymph nodes of head, face, and neck |
| C83.12 | Mantle cell lymphoma, intrathoracic lymph nodes |
| C83.13 | Mantle cell lymphoma, intra-abdominal lymph nodes |
| C83.14 | Mantle cell lymphoma, lymph nodes of axilla and upper limb |
| C83.15 | Mantle cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.16 | Mantle cell lymphoma, intrapelvic lymph nodes |
| C83.17 | Mantle cell lymphoma, spleen |
| C83.18 | Mantle cell lymphoma, lymph nodes of multiple sites |
| C83.19 | Mantle cell lymphoma, extranodal and solid organ sites |
| C90.0 | Multiple myeloma |
| C90.0 | Multiple myeloma |
| C90.00 | Multiple myeloma not having achieved remission |
| C90.00 | Multiple myeloma not having achieved remission |
| C90.02 | Multiple myeloma in relapse |
| D46.C | Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality |
Formulary Reference Tool